Serum chemokine profile in patients with bullous pemphigoid

British Journal of Dermatology

Volumn 156, Issue 3, 2007, Pages 454-459

  Nakashima, H ^a   Fujimoto, M ^b   Asashima, N ^a   Watanabe, R ^a   Kuwano, Y ^a   Yazawa, N ^a   Maruyama, N ^c   Okochi, H ^d   Kumanogoh, A ^e   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Autoimmunity; Bullous pemphigoid; Chemokine; Multiplex protein analysis system; Pemphigus vulgaris; Th1 Th2

Indexed keywords

CHEMOKINE; CXCL9 CHEMOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES;

AGED; ARTICLE; BLOOD SAMPLING; BULLOUS PEMPHIGOID; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; GROWTH REGULATION; HUMAN; MALE; ONCOGENE; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SERUM;

AGED; CHEMOKINE CCL2; CHEMOKINES; CHEMOKINES, CC; CHEMOKINES, CXC; FEMALE; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; MONOCYTE CHEMOATTRACTANT PROTEINS; PEMPHIGOID, BULLOUS; PEMPHIGUS; SEVERITY OF ILLNESS INDEX;

EID: 33846973321     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07601.x     Document Type: Article

References (25)

1. Labib RS, Anhalt GJ, Patel HP et al. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 1986; 136:1231-5.
2. Pastore S, Mascia F, Mariotti F et al. Chemokine networks in inflammatory skin diseases. Eur J Dermatol 2004; 14:203-8.
3. Tamaki K, So K, Furuya T et al. Cytokine profile of patients with bullous pemphigoid. Br J Dermatol 1994; 130:128-9.
4. Sun CC, Wu J, Wong TT et al. High levels of interleukin-8, soluble CD4 and soluble CD8 in bullous pemphigoid blister fluid. The relationship between local cytokine production and lesional T-cell activities. Br J Dermatol 2000; 143:1235-40.
5. Inaoki M, Takehara K. Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid. J Dermatol Sci 1998; 16:152-7.
6. D'Auria L, Pietravalle M, Mastroianni A et al. IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity. Arch Dermatol Res 1998; 290:25-7.
7. D'Auria L, Mussi A, Bonifati C et al. Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity. J Eur Acad Dermatol Venereol 1999; 12:11-15.
8. Ameglio F, D'Auria L, Bonifati C et al. Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity. Br J Dermatol 1998; 138:611-14.
9. Frezzolini A, Teofoli P, Cianchini G et al. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid. Eur J Dermatol 2002; 12:27-31.
10. Shrikhande M, Hunziker T, Braathen LR et al. Increased coexpression of eotaxin and interleukin 5 in bullous pemphigoid. Acta Derm Venereol (Stockh) 2000; 80:277-80.
11. Wakugawa M, Nakamura K, Hino H et al. Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia. Br J Dermatol 2000; 143:112-16.
12. Kakinuma T, Wakugawa M, Nakamura K et al. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid. Br J Dermatol 2003; 148:203-10.
13. Kagami S, Kakinuma T, Saeki H et al. Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid. J Invest Dermatol 2005; 124:1088-90.
14. Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187:129-34.
15. Koch AE, Kunkel SL, Harlow LA et al. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994; 93:921-8.
16. Tanaka Y, Adams DH, Hubscher S et al. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 1993; 361:79-82.
17. Sallusto F, Lenig D, Mackay CR et al. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187:875-83.
18. Budinger L, Borradori L, Yee C et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 1998; 102:2082-9.
19. Ponath PD, Qin S, Post TW et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 1996; 183:2437-48.
20. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277:2005-7.
21. Gerber BO, Zanni MP, Uguccioni M et al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr Biol 1997; 7:836-43.
22. Yoshimura T, Robinson EA, Tanaka S et al. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 1989; 169:1449-59.
23. Proost P, Wuyts A, van Damme J. Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J Leukoc Biol 1996; 59:67-74.
24. Vestergaard C, Just H, Baumgartner Nielsen J et al. Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis. Acta Derm Venereol (Stockh) 2004; 84:353-8.
25. Alam R, Stafford S, Forsythe P et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993; 150:3442-8.